Tag | Content |
---|
EnhancerAtlas ID | HS129-20854 |
Organism | Homo sapiens |
Tissue/cell | MCF10A |
Coordinate | chr2:173995130-173996160 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
RFX1 | MA0509.2 | chr2:173996087-173996103 | TGTTGCCATGGATACC | + | 6.38 | RFX1 | MA0509.2 | chr2:173996087-173996103 | TGTTGCCATGGATACC | - | 6.4 | RFX2 | MA0600.2 | chr2:173996087-173996103 | TGTTGCCATGGATACC | + | 6.49 | RFX2 | MA0600.2 | chr2:173996087-173996103 | TGTTGCCATGGATACC | - | 6.57 |
|
| Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
SE_35918 | chr2:173995083-173996503 | HMEC | SE_47134 | chr2:173995136-173998772 | Panc1 | SE_55735 | chr2:173994925-173996870 | u87 | SE_64574 | chr2:173994899-173996350 | NHEK |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH02I173130 | chr2 | 173994900 | 173998772 |
|
Enhancer Sequence | CTCAAAAATC AGAAACAAAA AGGGTAATGA GAATATGTCA GTATTTTTAT GCTATCAAGG 60 AGACAGGGAT ACTCATATTT TTATCCTGGA CTCTGGAATT AGTTGCTTCC CTCTCTGATG 120 TCTTCATCTG TAAAATGAGA GTTAAAAAAT AGAAAGATTG AAATCTTTCC AGTTTTAGAT 180 TTTAAATGCA CGTTCACTAA AGTGCAGAAT TAAATATGAT ATGAGAATGT GTTGGATCCT 240 GTCCAAAGTA TGCTGGTTAA CAGAGAACCA ACATGCTAGG GTGTGATCAG TCTGGGACGG 300 TGCTGAGCAC TGAGCTGTGA AAGTGTTCTA TATGGAACAG ACTTTGCGAT TCTGTTCTCA 360 GGACACTGTC TAGTAGATAA AATGAGACCA GCAGTGAGAC AGTGGGAATT CTTGCTGATG 420 ATTGTTTTAT GCCATGTAAG TGCAAAACAA CAACTTTAAC TGCACCAGGA TTCAGAATGT 480 GACAAGGTTT TAGGATCTAT CAAAATTCTA CTGAAACATG TGGCTATGAC TAAAACAAAT 540 AAGATGCTTC TAAGAACAGA TTGTGACTTG TCTATCAGCC CCTTTGAAAA CAATGTGCAT 600 GCTATTTATT AGGGATTGTA ATTACCTCAT GGAGTAATGG CATTTGCACA GTTTTTGTCT 660 GCCTCGATAA AAACCCTTGG CTGTGTCTGC TAACTTGGTG AAAAATCGCA GCAACAGAGG 720 CAGCCCAAGG ATCTTAAATC ATCCTGTGCA TACTCTCATT TTGTTTTTCT GCTGTGGCTT 780 TTACCCACTA GAGGGGATAG TGCATTGTCT CCAGGGAATT AGAGACTGTC ATATATGCCT 840 TATAGAATAC AAAGGAGCTT AAGTAATATA CACACATATA AAGTTACATG TACAGTAATT 900 GACATTAGGT GCTCCATTAA ACAATGAAAT GCCACAGTGT ACCAGTTCTT CAGGACATGT 960 TGCCATGGAT ACCCAGTGTG ATGGAGATAG GGAAAGAGTT GCTTAGGAAT TCAACGATTT 1020 CATTTTGAGG 1030
|